News
Malaysian Stocks Decline for Second Consecutive Session
Malaysian stocks experienced another day of decline on Wednesday, with the benchmark FTSE Bursa Malaysia KLCI (FBMKLCI) falling 0.4% to 1,457.60. Declining Stocks ...
News
Bumble Falls Short of Expectations
Bumble, the popular online dating company, has provided a disappointing outlook for the current quarter. For the fourth quarter ending on December 31st, ...
News
Akamai Technologies Reports Strong Q3 Results
Akamai Technologies, a leading content delivery network (CDN) provider, announced impressive financial results for the third quarter of this year. The company’s robust ...
News
Toast Inc. Lowers Full-Year Revenue Forecast, Shares Plummet
Shares of Toast Inc., a leading software and payments tools provider for the restaurant industry, took a hit in Tuesday’s extended session. The ...
News
Unlimited Funds Introduces Agile Replication Strategy
Unlimited Funds, the renowned investment firm co-founded by former Bridgewater Associates executive Bob Elliott, is unveiling a groundbreaking new investment strategy. Aptly named ...
News
Energy Information Administration Lowers Crude Oil Price Forecasts for 2024
The Energy Information Administration (EIA) has revised its forecasts for U.S. and global benchmark crude-oil prices in its latest Short-Term Energy Outlook report. ...
News
Enel Reports Impressive Profit Growth in First Nine Months
Enel, the Rome-based energy company, has announced a significant increase in profit for the first nine months of the year. Net profit soared ...
News
Tesla’s Evolution Towards Software: A New Outlook for Investors
Tesla, known for revolutionizing the car industry with its attractive electric vehicles (EVs), is now shifting its focus towards software. This strategic move ...
News
Ventyx Biosciences Inc. Shares Plummet after Halting Development of Psoriasis Treatments
Shares of Ventyx Biosciences Inc. (VTYX, -9.56%) dramatically plummeted by 73.7% during premarket trading on Tuesday. This significant decline comes after the biopharmaceutical ...


